Changing our world through 3D visualization.
The Oculenz AMD AR/XR headset (for low-vision patients) and StereoLenz 3D monitor (which allows users to see a 3D image without 3D glasses) are nearing commercialization, with seven additional products forthcoming. Reach out to get involved.
The company is currently acquiring capital, collecting pre-orders, and recruiting medical and scientific boards members.
Ocutrx obtains investments through referrals, Boustead Securities, Roth Capital Partners, and our Investor Relations team. For more information, please contact us.
Visual field test, AR
45 patent families
MedTiles, ORLenz, Or-Bot & Scopetrx have been filed and are pending.
Additional patents have been filed on features such as micro-displays, applications, connectivity, and more.